Blog

Stephanie Graff: Do All patients with node-positive breast cancer and low volume nodal disease need nodal radiotherapy?

Stephanie Graff/X

Sep 30, 2024, 16:17

Stephanie Graff: Do All patients with node-positive breast cancer and low volume nodal disease need nodal radiotherapy?

Stephanie Graff shared a post on X:

” All patients with node-positive breast cancer and low volume nodal disease need nodal radiotherapy.

Want “Show me the answers?”

Omission of axillary dissection in pts with low volume nodal disease undergoing upfront surgery is supported by evidence, but role of axillary radiation is unclear.

So, SGBCC invited internationally recognized experts to debate!

MARCH 2025

For more information.

Source: Stephanie Graff/X

Stephanie Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times.

Breast Cancer Breast Cancer Translational Research Disease Group Brown University cancer Legorreta Cancer Center Lifespan Cancer Institute nodal disease nodal radiotherapy OncoDaily Oncology SGBCC2025 Stephanie Graff

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage